Cerebriu recently obtained the CE-mark on its first product Cerebriu Apollo and is currently raising $2.2m to support further scientific research and implementation throughout hospitals in Europe. With the onset of the coronavirus COVID-19, the risk willingness of traders has reduced considerably, focusing on the perfect investment opportunities most likely to succeed.
Researchers in computer science and radiology have engineered the brand new technology for scanners. Cerebriu, which is stationed in Denmark and connects throughout the world, specializes in creating artificial intelligence (AI) for scanners to facilitate the work of radiologists for the benefit of sufferers.
The software solution makes it possible to detect the relevant areas, whereas the patient is in the scanner through image recognition. If there’s an area that should be scanned further, the software can tell doctors about this and set up an additional scan process immediately – and doctors will be made aware of one thing that could be acute.
The software program can also choose the images which have been found – thus saving radiologists from unnecessarily reviewing pictures that haven’t yielded results.
The Redefining Early Stage Investments (RESI) conference series was developed by Life Science Nation (LSN) to bring together startups with early-stage investors and strategic channel partners. The objective was to maximize the capability of those companies, from seed to series B, to find companions who’re a fit for their technology and stage of development.